Hesio

Hesio is an oral phlebotonic product containing the flavonoids diosmin and hesperidin. It is marketed in the European Union and is classified under ATC code C05CA03. The formulation combines these two active ingredients in a standardized ratio to support venous health. Hesio belongs to the drug class of phlebotonics and is used for chronic venous insufficiency and related conditions. It is supplied without a prescription in some markets.

Hesio is indicated for conditions associated with impaired venous return and capillary fragility.

- Chronic venous disease, including varicose veins and leg edema. - Mild to moderate hemorrhoidal disease (hemorrhoids). - Post‑thrombotic syndrome following deep vein thrombosis. - Venous stasis‑related skin changes such as lipodermatosclerosis. - Support of microcirculation in patients with peripheral vascular complaints. - Adjunct therapy for patients undergoing venous surgery or sclerotherapy.

Adverse reactions to Hesio are generally mild, but rare serious events have been reported.

Common: - Gastro‑intestinal discomfort such as nausea or abdominal pain. - Headache or dizziness. - Mild skin rash or pruritus. - Transient increase in blood pressure. - Diarrhea or loose stools. - Palpitations. - Fatigue or malaise.

Serious: - Severe allergic reaction (anaphylaxis, angioedema). - Hepatic enzyme elevation indicating liver injury. - Thrombotic events in predisposed individuals. - Bleeding disorders or coagulopathy.

When considering Hesio, certain safety considerations should be reviewed to minimize risk.

- Use with caution in patients with known hypersensitivity to flavonoids. - Assess liver function before initiating therapy, especially in those with hepatic disease. - Monitor blood pressure in individuals with hypertension. - Evaluate renal function in patients with chronic kidney disease. - Avoid use during pregnancy or lactation unless benefits outweigh risks. - Consider potential for drug‑induced photosensitivity in outdoor activities. - Discuss with a healthcare professional before combining with other vascular agents.

Hesio may interact with other medications, altering their effectiveness or safety profile.

Avoid: - Anticoagulants such as warfarin or direct oral anticoagulants. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that increase bleeding risk. - Other phlebotonic or venotonic agents that may cause additive effects.

Use with caution: - Antihypertensive drugs, as vasodilatory effects could enhance blood pressure lowering. - Hepatically metabolized drugs (e.g., statins, certain antidepressants) due to possible enzyme inhibition. - Herbal supplements containing high flavonoid content (e.g., grape seed extract).